Match Group Inc (MTCH) Opções

I didn't realizing she was hiding them.

True...

Agree, depends on market size of onc market they are in. I was speaking in general, but yes you're 100% right. Market size for R&D onc companies will help determine buyout price.

also to you, cheers!

Why don't you own a Tesla now?

I found this whole "scandal" refreshing.

We found out that the Trump administration public persona of not liking the two-faced con artists in Europe ripping us off for two generations and having us pay to defend them all these years while they laughed behind our backs matched what th

Not even close to being the same but nice try

Okay what's the difference roosty?

Most get snatched up in R&D phase at nice prices. 

The analysis didn't say manufacturing wouldn't start with artisan first.

For purposes of our discussion, his co-workers.

Wrong as usual zona! Bought low and still up a lot

Prove it.

MJNA .... https://investorshub.advfn.com/uimage/uploads/2023/1/7/xmwbvih2-bear.png ....Bearish
https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1cqursl*_gcl_au*OTA1MjAwNDc2LjE3NDExMTYwODY.

Agree. But often times, the onc pharma will have nothing at all or pocket change. Lol.
Ready to see another drug launch and a successful BE trial. Been a minute.

Nope. Instead, the most recent ASM occurred seven months after the MAA filing. Within the thick of the evaluation process, LP stated, on June 29th, 2024 that commercial would begin with commercial artisan manufacturing.

Yep, it's well reasoned. Certainly would explain things...

Before they reached 30,000 texts its good they got caught early on.....

Fresh pr here would setup a nice climb.

1.6bil left, but who is counting? It isn't a share selling scam. It was a real attempt at something big.

A dynamic leader? Ha!

Jour allow me to disagree

British drugmaker GSK (GSK.L), opens new tab said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of tumour.

Vs Vyvanse and adderall generics wit

Mine too! And I buy anything below .001 !!!
Shorts and flippers have to post daily. They trade for the short haul.
So they post nonsense and post endlessly. Pay them no heed.
Try not to play their game. Building any business is a long and difficult process
and short ga

Yep… guess not. It’s the Churchin’s versus the Christians. You know those people that go to Church and tithe every Sunday, showing up in front of their peers looking and speaking just right….and then when they leave, they bid good riddance to every word in the Bible.. of course not everyone here bec

Laugh. Vik is a diluter. His companies always fail.

LOL...there goes his promise not to drink if he gets the job!

Patient Affordability growth is outstanding!  And will continue.  Very strong Q1 nearly in the books followed by Q2 Gamma wildcard.   "Watershed year"  snug as a bug.  Nope, can't have my shares no matter the games played. Float will continue to shrink.  2-3 year hold max.  Thank you, Mark!